115 related articles for article (PubMed ID: 5273757)
1. Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VI. 1-Formylisoquinoline derivatives bearing additional ring substituents, with notes on mechanism of action.
French FA; Blanz EJ; DoAmaral JR; French DA
J Med Chem; 1970 Nov; 13(6):1117-24. PubMed ID: 5273757
[No Abstract] [Full Text] [Related]
2. Carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. VII. 2-Formylpyridine derivatives bearing additional ring substituents.
Blanz EJ; French FA; DoAmaral JR; French DA
J Med Chem; 1970 Nov; 13(6):1124-30. PubMed ID: 5273758
[No Abstract] [Full Text] [Related]
3. The carcinostatic activity of thiosemicarbazones of formyl heteroaromatic compounds. 3. Primary correlation.
French FA; Blanz EJ
J Med Chem; 1966 Jul; 9(4):585-9. PubMed ID: 5968028
[No Abstract] [Full Text] [Related]
4. The carcinostatic activity of 5-hydroxy-2-formylpyridine thiosemicarbazone.
Blanz EJ; French FA
Cancer Res; 1968 Dec; 28(12):2419-22. PubMed ID: 5728150
[No Abstract] [Full Text] [Related]
5. Potential antitumor agents. 3. Sodium salts of alpha-[N]-heterocyclic carboxaldehyde thiosemicarbazones.
Agrawal KC; Sartorelli AC
J Pharm Sci; 1968 Nov; 57(11):1948-51. PubMed ID: 5725927
[No Abstract] [Full Text] [Related]
6. The carcinostatic activity of alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazones. II. 3-Hydroxypyridine-2-carboxaldehyde thiosemicarbazone.
French FA; Blanz EJ
Cancer Res; 1966 Aug; 26(8):1638-40. PubMed ID: 5923162
[No Abstract] [Full Text] [Related]
7. Potential antitumor agents. II. Effects of modifications in the side chain of 1-formylisoquinoline thiosemicarbazone.
Agrawal KC; Sartorelli AC
J Med Chem; 1969 Sep; 12(5):771-4. PubMed ID: 5812185
[No Abstract] [Full Text] [Related]
8. Alpha-(N)-formylheteroaromatic thiosemicarbazones. Inhibition of tumor-derived ribonucleoside diphosphate reductase and correlation with in vivo antitumor activity.
French FA; Blanz EJ; Shaddix SC; Brockman RW
J Med Chem; 1974 Feb; 17(2):172-81. PubMed ID: 4809253
[No Abstract] [Full Text] [Related]
9. Elucidation of the structure of the antineoplastic agents, 2-formylpyridine and 1-formylisoquinoline thiosemicarbazones.
Antonini I; Claudi F; Franchetti P; Grifantini M; Martelli S
J Med Chem; 1977 Mar; 20(3):447-9. PubMed ID: 845876
[TBL] [Abstract][Full Text] [Related]
10. Kethoxal bis(thiosemicarbazone). I. Effects against experimental tumors.
Mihich E; Nichol CA
Cancer Res; 1965 Oct; 25(9):1410-6. PubMed ID: 5217028
[No Abstract] [Full Text] [Related]
11. Potential antitumor agents. 5. Methylated -(N)-heterocyclic carboxaldehyde thiosemicarbazones.
Agrawal KC; Cushley RJ; Lipsky SR; Wheaton JR; Sartorelli AC
J Med Chem; 1972 Feb; 15(2):192-5. PubMed ID: 5008241
[No Abstract] [Full Text] [Related]
12. Potential antitumor agents. IV. 4-substituted 1-formylisoquinoline thiosemicarbazones.
Agrawal KC; Cushley RJ; McMurray WJ; Sartorelli AC
J Med Chem; 1970 May; 13(3):431-4. PubMed ID: 5466487
[No Abstract] [Full Text] [Related]
13. Potential antineoplastics. V. Synthesis of ethyl 2,3-dioxobutyrate 2-arylhydrazono-3-thiosemicarbazones.
Garg HG; Sharma RA
J Med Chem; 1970 Sep; 13(5):991-2. PubMed ID: 5458402
[No Abstract] [Full Text] [Related]
14. Potential antitumor agents. 10. Synthesis and biochemical properties of 5-N-alkylamino-,N,N-dialkylamino-, and N-alkylacetamido-1-formylisoquinoline thiosemicarbazones.
Mooney PD; Booth BA; Moore EC; Agrawal KC; Sartorelli AC
J Med Chem; 1974 Nov; 17(11):1145-50. PubMed ID: 4370274
[No Abstract] [Full Text] [Related]
15. Evaluation of combination chemotherapy in vivo and in culture with l- -D-arabinofuranosylcytosine and 1-formylisoquinoline thiosemicarbazone.
Grindey GB; Mihich E; Nichol CA
Cancer Res; 1972 Mar; 32(3):522-6. PubMed ID: 5061306
[No Abstract] [Full Text] [Related]
16. The carcinostatic activity of alpha-(N) heterocyclic carboxaldehyde thiosemicarbazones. I. Isoquinoline-1-carboxaldehyde thiosemicarbazone.
French FA; Blanz EJ
Cancer Res; 1965 Oct; 25(9):1454-8. PubMed ID: 5862990
[No Abstract] [Full Text] [Related]
17. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of amino derivatives of pyridine-2-carboxaldehyde thiosemicarbazone.
Liu MC; Lin TS; Sartorelli AC
J Med Chem; 1992 Oct; 35(20):3672-7. PubMed ID: 1433178
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity of 3- and 5-hydroxy-4-methylpyridine-2-carboxaldehyde thiosemicarbazones.
Wang Y; Liu MC; Lin TS; Sartorelli AC
J Med Chem; 1992 Oct; 35(20):3667-71. PubMed ID: 1433177
[TBL] [Abstract][Full Text] [Related]
20. Potential carcinostatic agents. I. Derivatives and analogs of 1-(2-hydroxyethyl)-3-(4-tolyl)urea.
Nelson HG; Shelton FJ; Wetzel WH
J Med Chem; 1967 Jul; 10(4):735-6. PubMed ID: 6037073
[No Abstract] [Full Text] [Related]
[Next] [New Search]
